{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:01Z","timestamp":1793826001194,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UKHSA\/DHSC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Third-dose coronavirus disease 2019 vaccines are being deployed widely but their efficacy has not been assessed adequately in vulnerable older people who exhibit suboptimal responses after primary vaccination series. This observational study, which was carried out by the VIVALDI study based in England, looked at spike-specific immune responses in 341 staff and residents in long-term care facilities who received an mRNA vaccine following dual primary series vaccination with BNT162b2 or ChAdOx1. Third-dose vaccination strongly increased antibody responses with preferential relative enhancement in older people and was required to elicit neutralization of Omicron. Cellular immune responses were also enhanced with strong cross-reactive recognition of Omicron. However, antibody titers fell 21\u201378% within 100\u2009d after vaccine and 27% of participants developed a breakthrough Omicron infection. These findings reveal strong immunogenicity of a third vaccine in one of the most vulnerable population groups and endorse an approach for widespread delivery across this population. Ongoing assessment will be required to determine the stability of immune protection.<\/jats:p>","DOI":"10.1038\/s43587-022-00328-3","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T12:07:25Z","timestamp":1674216445000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0655-232X","authenticated-orcid":false,"given":"Gokhan","family":"Tut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2872-4794","authenticated-orcid":false,"given":"Tara","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Krutikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Sylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliska","family":"Spalkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8099-2024","authenticated-orcid":false,"given":"Christopher","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-8914","authenticated-orcid":false,"given":"Umayr","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8449-8584","authenticated-orcid":false,"given":"Azar","family":"Jadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Hulme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Tut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bruton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2074-6171","authenticated-orcid":false,"given":"Mary Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Crick COVID Immunity Pipeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbi","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Namjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Poulten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bawumia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Miah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Sade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes Cabrera","family":"Jarana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahbubur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Sandhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Caidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Caulfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorin","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Warchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Gavrielides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jag","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Strange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilayo","family":"Abiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Agau-Doce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svend","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00eb","family":"Roustan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Queval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Ulferts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Swanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Gamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Beale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8705-3281","authenticated-orcid":false,"given":"Oliver","family":"Stirrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-122X","authenticated-orcid":false,"given":"Madhumita","family":"Shrotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borscha","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verity","family":"Baynton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Irwin-Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Copas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-2555","authenticated-orcid":false,"given":"Laura","family":"Shallcross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-1967","authenticated-orcid":false,"given":"Paul","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"328_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/ageing\/afab060","volume":"50","author":"PF Dutey-Magni","year":"2021","unstructured":"Dutey-Magni, P. F. et al. COVID-19 infection and attributable mortality in UK care homes: cohort study using active surveillance and electronic records (March-June 2020). Age Ageing 50, 1019\u20131028 (2021).","journal-title":"Age Ageing"},{"key":"328_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","volume":"596","author":"DA Collier","year":"2021","unstructured":"Collier, D. A. et al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 596, 417\u2013422 (2021).","journal-title":"Nature"},{"key":"328_CR3","doi-asserted-by":"crossref","unstructured":"Shrotri, M. et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Lancet Infect. Dis. 21, 1529\u20131538 (2021).","DOI":"10.1016\/S1473-3099(21)00289-9"},{"key":"328_CR4","doi-asserted-by":"crossref","unstructured":"Tut, G. et al. Reduced antibody and cellular immune responses following dual COVID-19 vaccination within infection-na\u00efve residents of long-term care facilities. Lancet Healthy Longev. 3, e461\u2013e469 (2022).","DOI":"10.1016\/S2666-7568(22)00118-0"},{"key":"328_CR5","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S2666-7568(21)00093-3","volume":"2","author":"M Krutikov","year":"2021","unstructured":"Krutikov, M. et al. Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study. Lancet Healthy Longev. 2, e362\u2013e370 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"328_CR6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"328_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99\u2013111 (2021).","journal-title":"Lancet"},{"key":"328_CR8","first-page":"8012","volume":"25","author":"SA Meo","year":"2021","unstructured":"Meo, S. A., Meo, A. S., Al-Jassir, F. F. & Klonoff, D. C. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. Eur. Rev. Med. Pharm. Sci. 25, 8012\u20138018 (2021).","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"328_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12998\/wjcc.v10.i1.1","volume":"10","author":"SY Ren","year":"2022","unstructured":"Ren, S. Y., Wang, W. B., Gao, R. D. & Zhou, A. M. Omicron variant (B.1.1.529) of SARS-CoV-2: mutation, infectivity, transmission and vaccine resistance. World J. Clin. Cases 10, 1\u201311 (2022).","journal-title":"World J. Clin. Cases"},{"key":"328_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 602, 657\u2013663 (2022).","journal-title":"Nature"},{"key":"328_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","volume":"603","author":"R Keeton","year":"2022","unstructured":"Keeton, R. et al. T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature 603, 488\u2013492 (2022).","journal-title":"Nature"},{"key":"328_CR12","doi-asserted-by":"crossref","unstructured":"Krutikov, M. et al. & COVID-19 Genomics UK consortium. Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study. Lancet Healthy Longev. 3, e347\u2013e355 (2022). Erratum in: Lancet Healthy Longev. 3, e587 (2022).","DOI":"10.1016\/S2666-7568(22)00093-9"},{"key":"328_CR13","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","volume":"398","author":"SSA Karim","year":"2021","unstructured":"Karim, S. S. A. & Karim, Q. A. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet 398, 2126\u20132128 (2021).","journal-title":"Lancet"},{"key":"328_CR14","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2666-7568(21)00282-8","volume":"3","author":"M Krutikov","year":"2022","unstructured":"Krutikov, M. et al. Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England. Lancet Healthy Longev. 3, e13\u2013e21 (2022).","journal-title":"Lancet Healthy Longev."},{"key":"328_CR15","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S1473-3099(21)00289-9","volume":"21","author":"M Shrotri","year":"2021","unstructured":"Shrotri, M. et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Lancet Infect. Dis. 21, 1529\u20131538 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"328_CR16","doi-asserted-by":"publisher","first-page":"e544","DOI":"10.1016\/S2666-7568(21)00168-9","volume":"2","author":"G Tut","year":"2021","unstructured":"Tut, G. et al. Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study. Lancet Healthy Longev. 2, e544\u2013e553 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"328_CR17","doi-asserted-by":"publisher","first-page":"o30","DOI":"10.1136\/bmj.o30","volume":"376","author":"G Iacobucci","year":"2022","unstructured":"Iacobucci, G. COVID-19: fourth vaccine doses\u2014who needs them and why? BMJ 376, o30 (2022).","journal-title":"BMJ"},{"key":"328_CR18","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1172\/JCI64096","volume":"123","author":"E Montecino-Rodriguez","year":"2013","unstructured":"Montecino-Rodriguez, E., Berent-Maoz, B & Dorshkind, K. Causes, consequences, and reversal of immune system aging. J. Clin. Invest. 123, 958\u2013965 (2013).","journal-title":"J. Clin. Invest."},{"key":"328_CR19","doi-asserted-by":"crossref","unstructured":"Bajaj, V. et al. Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections? Front. Physiol. 11, 571416 (2021).","DOI":"10.3389\/fphys.2020.571416"},{"key":"328_CR20","doi-asserted-by":"publisher","first-page":"e695","DOI":"10.1093\/cid\/ciab998","volume":"75","author":"P Pannus","year":"2022","unstructured":"Pannus, P. et al. Poor antibody response to BioNTech\/Pfizer coronavirus disease 2019 vaccination in severe acute respiratory syndrome coronavirus 2-naive residents of nursing homes. Clin. Infect. Dis. 75, e695\u2013e704 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"328_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","volume":"596","author":"DA Collier","year":"2021","unstructured":"Collier, D. A. et al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 596, 417\u2013422 (2021).","journal-title":"Nature"},{"key":"328_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12979-021-00219-y","volume":"18","author":"G Pawelec","year":"2021","unstructured":"Pawelec, G. & McElhaney, J. Unanticipated efficacy of SARS-CoV-2 vaccination in older adults. Immun. Ageing 18, 7 (2021).","journal-title":"Immun. Ageing"},{"key":"328_CR23","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMc2035906","volume":"384","author":"M Krutikov","year":"2021","unstructured":"Krutikov, M., Hayward, A. & Shallcross, L. Spread of a variant SARS-CoV-2 in long-term care facilities in England. N. Engl. J. Med. 384, 1671\u20131673 (2021).","journal-title":"N. Engl. J. Med."},{"key":"328_CR24","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1126\/science.abh1282","volume":"372","author":"CJ Reynolds","year":"2021","unstructured":"Reynolds, C. J. et al. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science 372, 1418\u20131423 (2021).","journal-title":"Science"},{"key":"328_CR25","doi-asserted-by":"crossref","unstructured":"Cohen, H. et al. T cell response following anti-COVID-19 BNT162b2 vaccination is maintained against the SARS-CoV-2 Omicron B.1.1.529 variant of concern. Viruses 14, 347 (2022).","DOI":"10.3390\/v14020347"},{"key":"328_CR26","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","volume":"185","author":"V Naranbhai","year":"2022","unstructured":"Naranbhai, V. et al. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell 185, 1041\u20131051 (2022).","journal-title":"Cell"},{"key":"328_CR27","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S1473-3099(22)00271-7","volume":"22","author":"APS Munro","year":"2022","unstructured":"Munro, A. P. S. et al. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. Lancet Infect. Dis. 22, 1131\u20131141 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"328_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s43587-022-00224-w","volume":"2","author":"G Tut","year":"2022","unstructured":"Tut, G. et al. Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-na\u00efve residents of long-term care facilities who survive natural infection. Nat. Aging 2, 536\u2013547 (2022).","journal-title":"Nat. Aging"},{"key":"328_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","volume":"48","author":"BV Kumar","year":"2018","unstructured":"Kumar, B. V., Connors, T. J. & Farber, D. L. Human T cell development, localization, and function throughout life. Immunity 48, 202\u2013213 (2018).","journal-title":"Immunity"},{"key":"328_CR30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0140-6736(22)00092-7","volume":"399","author":"M Wu","year":"2022","unstructured":"Wu, M. et al. Three-dose vaccination elicits neutralising antibodies against omicron. Lancet 399, 715\u2013717 (2022).","journal-title":"Lancet"},{"key":"328_CR31","doi-asserted-by":"publisher","first-page":"e69317","DOI":"10.7554\/eLife.69317","volume":"10","author":"N Faulkner","year":"2021","unstructured":"Faulkner, N. et al. Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains.Elife 10, e69317 (2021).","journal-title":"Elife"}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-022-00328-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-022-00328-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-022-00328-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T12:15:38Z","timestamp":1674216938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-022-00328-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["328"],"URL":"https:\/\/doi.org\/10.1038\/s43587-022-00328-3","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"assertion":[{"value":"10 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.S. reports grants from the Department of Health and Social Care during the conduct of the study and is a member of the Social Care Working Group, which reports to the Scientific Advisory Group for Emergencies. A.H. is a member of the New and Emerging Respiratory Virus Threats Advisory Group at the Department of Health. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}